The António Champalimaud Vision Award, established by the Champalimaud Foundation in 2006, honors outstanding contributions to the preservation and understanding of sight. Seven ARVO members were named as the recipients of the 2014 Antonio Champalimaud Vision Award, the highest distinction in ophthalmology and visual science, for their pioneering work to treat age-related macular degeneration (AMD) and diabetic retinopathy, the most important causes of blindness in high- and middle-income countries.#AM2015 #Lecture #Denver
Discovery of VEGF-A, a Key Regulator of Intraocular Neovascularization00:25:12
VEGF: from discovery to therapy00:15:39
Introductory remarks00:21:20